With the advancement of surgical and radiation therapy strategies for stage 1 non-small-cell lung cancer (NSCLC), more patients are being treated, resulting in higher survival rates, according to a study published online ...
Oct 26, 2017
0
1
Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small ...
Dec 10, 2018
0
155
Early signs that a patient's lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers published in Nature Medicine today.
Oct 7, 2019
0
172
Lung cancer spreads to the brain in about one-quarter of patients with an advanced form of the disease. To date, radiation has been the only treatment option, but it comes with toxic side effects. Researchers at Yale Cancer ...
Apr 14, 2020
0
302
A leading-edge immunotherapy clinical trial at UConn Health's Carole and Ray Neag Comprehensive Cancer Center has packed a one-two punch, successfully controlling a patient's advanced lung cancer using the combined power ...
Dec 14, 2016
0
72
Knowing whether a tumor might grow or spread to other parts of a patient's body could be key to survival—and now scientists are one step closer to unlocking the ability to predict just that.
Apr 13, 2023
0
72
Fat isn't just something we eat: it may also lie at the heart of a new approach to treating cancer.
Sep 19, 2016
0
91
Lung cancer remains the leading cause of cancer-related deaths worldwide. In contrast to other tumour types, lung tumours present a high number of genomic alterations—this is a consequence of exposure to carcinogenic substances ...
Dec 6, 2016
0
28
New research led by scientists at the Medical Research Council (MRC) Toxicology Unit suggests that by analysing levels of DNA in the blood, the early detection of lung cancer could be improved.
Feb 12, 2019
0
241
New insights into a population of tumor-infiltrating T cells may ultimately allow doctors to predict how patients will respond to checkpoint blockade immunotherapy, a form of cancer treatment with advantages that doctors ...
